DNA crosslinking and recombination-activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia.
Zhang, H., Cheng, N., Li, Z., Bai, L., Fang, C., Li, Y., Zhang, W., Dong, X., Jiang, M., Liang, Y., Zhang, S., Mi, J., Zhu, J., Zhang, Y., Chen, S.J., Zhao, Y., Weng, X.Q., Hu, W., Chen, Z., Huang, J., Meng, G.(2021) Cancer Commun (Lond) 41: 1116-1136
- PubMed: 34699692 
- DOI: https://doi.org/10.1002/cac2.12234
- Primary Citation of Related Structures:  
7DW5 - PubMed Abstract: 
Abnormal alternative splicing is frequently associated with carcinogenesis. In B-cell acute lymphoblastic leukemia (B-ALL), double homeobox 4 fused with immunoglobulin heavy chain (DUX4/IGH) can lead to the aberrant production of E-26 transformation-specific family related gene abnormal transcript (ERG alt ) and other splicing variants. However, the molecular mechanism underpinning this process remains elusive. Here, we aimed to know how DUX4/IGH triggers abnormal splicing in leukemia.
Organizational Affiliation: 
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, School of Medicine and School of Life Sciences and Biotechnology, Shanghai JiaoTong University, Shanghai, 200025, P. R. China.